Jarielle Carter
Family · Warner Robins, GANPI 1659926756
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.6% of the total across 344 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 45 manufacturers, the largest accounting for just 18.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,847 and has fallen 83.3% since, to $308 in 2025. Among family clinicians in GA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 344 payments — averaging $19.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Pfizer$591
- Lilly USA, LLC$526
- Johnson & Johnson$506
- Amgen$358
- Otsuka America Pharmaceutical, Inc.$357
- plus $3K from 39 others
What the payments were for
- Food & beverage$6,72799%
- Education$951%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,822 in reported general payments places this provider in the 95th percentile of 6,258 family providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 146 | $214,767 |
| MounjaroTirzepatide | 103 | $164,440 |
| FarxigaDapagliflozin Propanediol | 139 | $130,405 |
| LinzessLinaclotide | 113 | $92,681 |
| EliquisApixaban | 69 | $69,839 |
| TrulicityDulaglutide | 49 | $63,959 |
| JardianceEmpagliflozin | 62 | $50,846 |
| VraylarCariprazine Hcl | 25 | $34,176 |
| XareltoRivaroxaban | 40 | $34,043 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 36 | $30,317 |
| MyrbetriqMirabegron | 34 | $29,435 |
| RybelsusSemaglutide | 16 | $29,408 |
| JanuviaSitagliptin Phosphate | 33 | $21,972 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 30 | $19,214 |
| UbrelvyUbrogepant | 11 | $17,119 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $312 | $244,175162 claims |
| Lilly USA, LLCMounjaro, Trulicity | $526 | $228,399152 claims |
| AbbVieLinzess, Vraylar, Ubrelvy, Qulipta | $1,243 | $161,089163 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $242 | $156,257189 claims |
| Boehringer IngelheimJardiance, Tradjenta, Stiolto Respimat, Spiriva Respimat | $100 | $92,071133 claims |
| PfizerEliquis | $591 | $69,83969 claims |
| GSKTrelegy Ellipta, Breo Ellipta | $123 | $34,67747 claims |
| Johnson & JohnsonXarelto | $506 | $34,04340 claims |
| MerckJanuvia, Janumet | $122 | $29,06846 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,258 family providers in Georgia.
Other family in Warner Robins
- Kelly MurrayWarner Robins$18K
- Allie McAllisterMarietta$299K
- Erin HenryLawrenceville$135K
- Trisha RomanPeachtree City$134K
- Lori ReedMarietta$106K
- Julia BranchCumming$102K
- Hannah BanachWaycross$85K
- Morgan GroothandEvans$81K
- Anna Carolina WrightLilburn$69K
- Jessica FeehanCanton$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.